MedTrace Logo

Efficacy of HFNC as an Alternative to CPAP Therapy in Surgical Patients With Suspected Moderate to Severe OSA

NCT05075668 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-10-13

No results posted yet for this study

Summary

High flow, humidified, temperature-regulated nasal insufflation is not a new concept. It is used widely in the treatment of hypoxaemic respiratory failure in critically ill patients, as an alternative to non-invasive positive ventilation via face or nasal mask. Recently, its use has been extended to the perioperative setting for pre-oxygenation and prolonging apnoeic time to desaturation. Both CPAP and high flow nasal cannula insufflation devices are licensed for use clinically in Singapore. We conduct this pilot study because its perioperative use in our adult OSA population is currently not well-defined.

Conditions

  • OSA

Interventions

DEVICE

CPAP face mask

Two types of CPAP therapy for OSA support are compared; CPAP face mask vs HFNC at different flow rates

DEVICE

High flow nasal cannula (HFNC)

Two types of CPAP therapy for OSA support are compared; CPAP face mask vs HFNC at different flow rates

Sponsors & Collaborators

  • Changi General Hospital

    lead OTHER

Principal Investigators

  • Fung Chen Tsai, MMED (Anaes) · Changi General Hospital, SingHealth

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-13
Primary Completion
2020-07-31
Completion
2020-07-31

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05075668 on ClinicalTrials.gov